Market Outlook
The global Cardiopulmonary Assist System (ECMO) market size was valued at USD 301.5 million in 2022 and is forecast to a readjusted size of USD 402.4 million by 2029 with a CAGR of 4.2% during review period.
ECMO is used for long-term extracorporeal respiratory and circulatory support for patients, replacing the functions of the patient's own heart and lungs, completing oxygenation of blood outside the body and expelling carbon dioxide.
Report includes an overview of the development of the Cardiopulmonary Assist System(ECMO) industry chain, the market status of Adult (V-V-ECMO, V-A-ECM), Newborn (V-V-ECMO, V-A-ECM), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Cardiopulmonary Assist System(ECMO).
Regionally, the report analyzes the Cardiopulmonary Assist System(ECMO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cardiopulmonary Assist System(ECMO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cardiopulmonary Assist System(ECMO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cardiopulmonary Assist System(ECMO) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., V-V-ECMO, V-A-ECM).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cardiopulmonary Assist System(ECMO) market.
Regional Analysis: The report involves examining the Cardiopulmonary Assist System(ECMO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cardiopulmonary Assist System(ECMO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cardiopulmonary Assist System(ECMO):
Company Analysis: Report covers individual Cardiopulmonary Assist System(ECMO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Cardiopulmonary Assist System(ECMO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adult, Newborn).
Technology Analysis: Report covers specific technologies relevant to Cardiopulmonary Assist System(ECMO). It assesses the current state, advancements, and potential future developments in Cardiopulmonary Assist System(ECMO) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cardiopulmonary Assist System(ECMO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Key Market Players
Getinge
LivaNova
Medtronic
Terumo Cardiovascular
Fresenius
Shenzhen Hannuo Medical Technology
Segmentation By Type
V-V-ECMO
V-A-ECM
Segmentation By Application
Adult
Newborn
Child
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Cardiopulmonary Assist System (ECMO) market in 2025?
The ECMO market benefits from increasing demand due to rising incidences of heart and lung diseases, along with advancements in technology that improve the efficiency and safety of ECMO devices. This is further supported by the growing healthcare infrastructure in emerging markets.
What are the weaknesses of the Cardiopulmonary Assist System (ECMO) market in 2025?
One major weakness is the high cost of ECMO systems and their maintenance, which can limit adoption, especially in low-resource settings. Additionally, there are concerns regarding the complexity of operation and the need for highly trained personnel.
What are the opportunities in the Cardiopulmonary Assist System (ECMO) market in 2025?
With the ongoing development of portable and more user-friendly ECMO devices, there is a great opportunity to expand their use beyond critical care units into home settings and emergency transport. The growing prevalence of chronic respiratory and cardiac conditions also opens avenues for market expansion.
What are the threats to the Cardiopulmonary Assist System (ECMO) market in 2025?
The ECMO market faces the threat of competition from other mechanical circulatory support devices, such as ventricular assist devices (VADs). Additionally, regulatory challenges and safety concerns may hinder market growth and adoption, especially in developing regions.
Market PESTEL Analysis
What are the political factors influencing the Cardiopulmonary Assist System (ECMO) market in 2025?
Government policies and healthcare regulations play a critical role in the adoption of ECMO systems. Political stability and support for healthcare investments in both developed and emerging markets can boost market growth, while any changes in healthcare funding or regulation could impact its accessibility.
What are the economic factors impacting the ECMO market in 2025?
The ECMO market is affected by the overall economic conditions, particularly healthcare spending in different regions. High costs associated with ECMO devices and treatments may hinder adoption in low-income countries. Economic growth in emerging markets, however, presents an opportunity for increased demand.
What are the social factors shaping the ECMO market in 2025?
Increasing awareness of heart and lung diseases, along with a growing aging population, raises the demand for advanced cardiopulmonary assistance systems like ECMO. Furthermore, patient expectations for better healthcare outcomes push the need for advanced technologies in critical care.
What are the technological factors affecting the ECMO market in 2025?
Technological advancements in ECMO systems, such as miniaturization, portability, and improved efficiency, are key drivers. The integration of AI and remote monitoring is improving patient outcomes and expanding the reach of ECMO systems, especially in remote or under-resourced areas.
What are the environmental factors influencing the ECMO market in 2025?
The environmental impact of ECMO devices, including energy consumption and medical waste, is an area of concern. As hospitals and healthcare providers increasingly focus on sustainability, innovations in eco-friendly devices and waste reduction may become more important for the market.
What are the legal factors that affect the ECMO market in 2025?
Strict regulatory requirements for medical devices, including safety standards and approvals by health authorities like the FDA and EMA, can slow down the introduction of new ECMO technologies. Legal issues related to liability and patient safety also influence market dynamics.
Market SIPOC Analysis
Who are the suppliers in the ECMO market in 2025?
The suppliers in the ECMO market include manufacturers of medical equipment, technology providers for software integration and monitoring systems, and suppliers of consumables like cannulas, tubing, and oxygenators. They also include component suppliers for pumps, valves, and other critical parts of ECMO devices.
What are the inputs required for the ECMO market in 2025?
Key inputs include raw materials for device manufacturing, research and development (R&D) for new technology, skilled labor for assembly, and regulatory approvals for devices. Additional inputs include data for performance optimization, medical consumables, and specialized training for healthcare personnel.
What are the processes involved in the ECMO market in 2025?
The processes in the ECMO market involve the development and manufacturing of ECMO machines, followed by clinical trials to ensure safety and efficacy. After receiving regulatory approval, the devices are distributed to hospitals, where trained medical professionals operate them in critical care settings for patients in need of cardiopulmonary support.
Who are the customers in the ECMO market in 2025?
The customers include hospitals, specialized cardiac and respiratory care centers, and healthcare systems globally. Additionally, emergency medical services (EMS) providers, research institutions, and private clinics may also be customers, especially in regions with growing healthcare demands.
What are the outputs of the ECMO market in 2025?
The primary outputs of the ECMO market include fully functional ECMO devices, accessories like oxygenators and cannulas, and related services such as training and ongoing maintenance. Additionally, the market provides enhanced patient outcomes through improved cardiopulmonary support and recovery rates.
Market Porter's Five Forces
What is the threat of new entrants in the ECMO market in 2025?
The threat of new entrants in the ECMO market is relatively low due to high barriers to entry, including significant capital investment, complex technology development, stringent regulatory requirements, and the need for specialized expertise. Established companies with existing market share and reputation hold a strong competitive advantage.
What is the bargaining power of suppliers in the ECMO market in 2025?
The bargaining power of suppliers is moderate to high. While there are multiple suppliers for components, high-quality and specialized materials such as pumps, oxygenators, and cannulas are crucial, giving certain suppliers more leverage. Additionally, the need for advanced technology and regulatory compliance often limits options.
What is the bargaining power of buyers in the ECMO market in 2025?
The bargaining power of buyers is moderate. Hospitals and healthcare providers are large buyers, but the specialized nature of ECMO systems and their high cost reduces the number of purchasing options. Despite this, as more hospitals invest in ECMO technology, competition among manufacturers could increase, offering buyers some negotiating power.
What is the threat of substitutes in the ECMO market in 2025?
The threat of substitutes is moderate. While there are other mechanical circulatory support devices, such as ventricular assist devices (VADs), ECMO remains the preferred choice in certain critical care situations. However, advances in alternative technologies and treatments could pose a long-term threat as they become more effective or accessible.
What is the intensity of competitive rivalry in the ECMO market in 2025?
The intensity of competitive rivalry is high. The ECMO market has a few dominant players, but the increasing demand for advanced, cost-effective, and portable systems is pushing companies to innovate. Competition for market share is particularly fierce in both established markets and emerging economies.
Market Upstream Analysis
What are the key raw materials needed for the ECMO market in 2025?
The key raw materials required for ECMO devices include specialized metals and polymers for the construction of pumps, oxygenators, and cannulas. High-quality plastics and rubber are also essential for tubing and seals. Additionally, electronic components, sensors, and microprocessors are critical for the system’s functionality.
What are the technological inputs for the ECMO market in 2025?
Technological inputs include research and development in fluid dynamics, pump technology, and biocompatible materials. Advances in software for monitoring and controlling ECMO systems, as well as innovations in miniaturization and portability, are also significant technological inputs for the market.
How does the supply chain for ECMO systems operate in 2025?
The supply chain for ECMO systems involves manufacturers of components like pumps, tubing, oxygenators, and electronics, who supply these parts to ECMO device manufacturers. After assembly, the completed devices are distributed to hospitals, healthcare systems, and medical device vendors. Additionally, consumables and replacement parts are supplied through specialized channels to maintain the devices.
What are the regulatory requirements impacting the ECMO market in 2025?
ECMO devices must meet stringent regulatory standards set by health authorities such as the FDA, EMA, and other national bodies. Manufacturers must comply with medical device safety regulations, quality control standards, and conduct clinical trials to ensure the efficacy and safety of their products before market approval.
What are the challenges in sourcing components for ECMO systems in 2025?
Challenges in sourcing components include ensuring high-quality standards for biocompatible materials and electronics, the complexity of sourcing specialized parts, and managing supply chain disruptions. Additionally, fluctuations in raw material prices and geopolitical factors can create uncertainty in the procurement of components.
Market Midstream Analysis
What are the key players involved in the midstream stage of the ECMO market in 2025?
Key players in the midstream stage include manufacturers of ECMO devices, assembly plants, and research organizations. These companies are responsible for assembling, testing, and refining the components sourced from suppliers before the final device is ready for distribution to healthcare providers.
How does the manufacturing process impact the ECMO market in 2025?
The manufacturing process is critical in ensuring the quality, reliability, and safety of ECMO systems. Manufacturers must adhere to strict quality control standards and regulatory requirements, which can increase production costs. Efficient manufacturing processes can also reduce lead times and improve scalability to meet the growing demand for ECMO systems.
What are the distribution channels for ECMO systems in 2025?
ECMO systems are primarily distributed through direct sales to hospitals and healthcare providers, as well as through medical device distributors. Specialized distributors and sales representatives play a key role in promoting and delivering ECMO systems to critical care units, intensive care units (ICUs), and specialized cardiac care centers.
What role do service providers play in the midstream ECMO market in 2025?
Service providers, including maintenance and training companies, play a critical role in ensuring the proper functioning of ECMO systems. They offer after-sales support, regular maintenance, and training for medical personnel to operate the devices. This enhances the long-term effectiveness and safety of ECMO treatment.
What challenges exist in the midstream segment of the ECMO market in 2025?
Challenges in the midstream segment include ensuring the timely delivery of high-quality, reliable devices amidst supply chain disruptions and maintaining compliance with evolving regulatory standards. Additionally, the high costs associated with R&D, manufacturing, and distribution of advanced ECMO systems may limit profitability for manufacturers.
Market Downstream Analysis
Who are the key stakeholders in the downstream segment of the ECMO market in 2025?
The key stakeholders in the downstream segment include hospitals, healthcare providers, intensive care units (ICUs), cardiac and pulmonary care centers, and emergency medical services (EMS). Additionally, patients, physicians, and healthcare professionals involved in ECMO procedures are also crucial stakeholders.
What is the role of hospitals in the downstream ECMO market in 2025?
Hospitals are the primary users of ECMO systems, particularly in critical care and emergency settings. They are responsible for adopting and maintaining ECMO technology, ensuring it is used properly in patient care. Hospitals also invest in training medical staff and maintaining ECMO devices for long-term functionality.
How does the adoption of ECMO systems by healthcare providers affect the market in 2025?
The adoption of ECMO systems by healthcare providers drives market growth by increasing demand for advanced cardiac and pulmonary support technologies. As more hospitals integrate ECMO into their critical care protocols, this expands the market for both the devices and related services, such as maintenance and training.
What are the challenges faced by healthcare providers in the downstream ECMO market in 2025?
Healthcare providers face challenges such as the high cost of ECMO systems and their maintenance, which may limit adoption, especially in resource-constrained regions. Additionally, the need for specialized training and the complexity of operating ECMO systems can also create barriers to effective use.
What are the emerging trends in the downstream ECMO market in 2025?
Emerging trends in the downstream ECMO market include the increasing focus on patient outcomes and the use of portable, less invasive ECMO systems. There is also a growing emphasis on telemedicine and remote monitoring of ECMO patients, allowing healthcare providers to manage cases more effectively and reduce the need for on-site interventions.
Chapter 1, to describe Cardiopulmonary Assist System(ECMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiopulmonary Assist System(ECMO), with price, sales, revenue and global market share of Cardiopulmonary Assist System(ECMO) from 2018 to 2023.
Chapter 3, the Cardiopulmonary Assist System(ECMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiopulmonary Assist System(ECMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiopulmonary Assist System(ECMO) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiopulmonary Assist System(ECMO).
Chapter 14 and 15, to describe Cardiopulmonary Assist System(ECMO) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Assist System(ECMO)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 V-V-ECMO
1.3.3 V-A-ECM
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Aldult
1.4.3 Newborn
1.4.4 Child
1.5 Global Cardiopulmonary Assist System(ECMO) Market Size & Forecast
1.5.1 Global Cardiopulmonary Assist System(ECMO) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cardiopulmonary Assist System(ECMO) Sales Quantity (2018-2029)
1.5.3 Global Cardiopulmonary Assist System(ECMO) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Getinge
2.1.1 Getinge Details
2.1.2 Getinge Major Business
2.1.3 Getinge Cardiopulmonary Assist System(ECMO) Product and Services
2.1.4 Getinge Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Getinge Recent Developments/Updates
2.2 LivaNova
2.2.1 LivaNova Details
2.2.2 LivaNova Major Business
2.2.3 LivaNova Cardiopulmonary Assist System(ECMO) Product and Services
2.2.4 LivaNova Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 LivaNova Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Cardiopulmonary Assist System(ECMO) Product and Services
2.3.4 Medtronic Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo Cardiovascular
2.4.1 Terumo Cardiovascular Details
2.4.2 Terumo Cardiovascular Major Business
2.4.3 Terumo Cardiovascular Cardiopulmonary Assist System(ECMO) Product and Services
2.4.4 Terumo Cardiovascular Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Terumo Cardiovascular Recent Developments/Updates
2.5 Fresenius
2.5.1 Fresenius Details
2.5.2 Fresenius Major Business
2.5.3 Fresenius Cardiopulmonary Assist System(ECMO) Product and Services
2.5.4 Fresenius Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fresenius Recent Developments/Updates
2.6 Shenzhen Hannuo Medical Technology
2.6.1 Shenzhen Hannuo Medical Technology Details
2.6.2 Shenzhen Hannuo Medical Technology Major Business
2.6.3 Shenzhen Hannuo Medical Technology Cardiopulmonary Assist System(ECMO) Product and Services
2.6.4 Shenzhen Hannuo Medical Technology Cardiopulmonary Assist System(ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shenzhen Hannuo Medical Technology Recent Developments/Updates
3 Competitive Environment: Cardiopulmonary Assist System(ECMO) by Manufacturer
3.1 Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cardiopulmonary Assist System(ECMO) Revenue by Manufacturer (2018-2023)
3.3 Global Cardiopulmonary Assist System(ECMO) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cardiopulmonary Assist System(ECMO) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cardiopulmonary Assist System(ECMO) Manufacturer Market Share in 2022
3.4.2 Top 6 Cardiopulmonary Assist System(ECMO) Manufacturer Market Share in 2022
3.5 Cardiopulmonary Assist System(ECMO) Market: Overall Company Footprint Analysis
3.5.1 Cardiopulmonary Assist System(ECMO) Market: Region Footprint
3.5.2 Cardiopulmonary Assist System(ECMO) Market: Company Product Type Footprint
3.5.3 Cardiopulmonary Assist System(ECMO) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cardiopulmonary Assist System(ECMO) Market Size by Region
4.1.1 Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2018-2029)
4.1.2 Global Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2018-2029)
4.1.3 Global Cardiopulmonary Assist System(ECMO) Average Price by Region (2018-2029)
4.2 North America Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029)
4.3 Europe Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029)
4.4 Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029)
4.5 South America Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029)
4.6 Middle East and Africa Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
5.2 Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type (2018-2029)
5.3 Global Cardiopulmonary Assist System(ECMO) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
6.2 Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application (2018-2029)
6.3 Global Cardiopulmonary Assist System(ECMO) Average Price by Application (2018-2029)
7 North America
7.1 North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
7.2 North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
7.3 North America Cardiopulmonary Assist System(ECMO) Market Size by Country
7.3.1 North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2029)
7.3.2 North America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
8.2 Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
8.3 Europe Cardiopulmonary Assist System(ECMO) Market Size by Country
8.3.1 Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2029)
8.3.2 Europe Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cardiopulmonary Assist System(ECMO) Market Size by Region
9.3.1 Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
10.2 South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
10.3 South America Cardiopulmonary Assist System(ECMO) Market Size by Country
10.3.1 South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2029)
10.3.2 South America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cardiopulmonary Assist System(ECMO) Market Size by Country
11.3.1 Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cardiopulmonary Assist System(ECMO) Market Drivers
12.2 Cardiopulmonary Assist System(ECMO) Market Restraints
12.3 Cardiopulmonary Assist System(ECMO) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Cardiopulmonary Assist System(ECMO) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiopulmonary Assist System(ECMO)
13.3 Cardiopulmonary Assist System(ECMO) Production Process
13.4 Cardiopulmonary Assist System(ECMO) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiopulmonary Assist System(ECMO) Typical Distributors
14.3 Cardiopulmonary Assist System(ECMO) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Getinge Basic Information, Manufacturing Base and Competitors
Table 4. Getinge Major Business
Table 5. Getinge Cardiopulmonary Assist System(ECMO) Product and Services
Table 6. Getinge Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Getinge Recent Developments/Updates
Table 8. LivaNova Basic Information, Manufacturing Base and Competitors
Table 9. LivaNova Major Business
Table 10. LivaNova Cardiopulmonary Assist System(ECMO) Product and Services
Table 11. LivaNova Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. LivaNova Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Cardiopulmonary Assist System(ECMO) Product and Services
Table 16. Medtronic Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Terumo Cardiovascular Basic Information, Manufacturing Base and Competitors
Table 19. Terumo Cardiovascular Major Business
Table 20. Terumo Cardiovascular Cardiopulmonary Assist System(ECMO) Product and Services
Table 21. Terumo Cardiovascular Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Terumo Cardiovascular Recent Developments/Updates
Table 23. Fresenius Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Major Business
Table 25. Fresenius Cardiopulmonary Assist System(ECMO) Product and Services
Table 26. Fresenius Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fresenius Recent Developments/Updates
Table 28. Shenzhen Hannuo Medical Technology Basic Information, Manufacturing Base and Competitors
Table 29. Shenzhen Hannuo Medical Technology Major Business
Table 30. Shenzhen Hannuo Medical Technology Cardiopulmonary Assist System(ECMO) Product and Services
Table 31. Shenzhen Hannuo Medical Technology Cardiopulmonary Assist System(ECMO) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Shenzhen Hannuo Medical Technology Recent Developments/Updates
Table 33. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Cardiopulmonary Assist System(ECMO) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Cardiopulmonary Assist System(ECMO) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Cardiopulmonary Assist System(ECMO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Cardiopulmonary Assist System(ECMO) Production Site of Key Manufacturer
Table 38. Cardiopulmonary Assist System(ECMO) Market: Company Product Type Footprint
Table 39. Cardiopulmonary Assist System(ECMO) Market: Company Product Application Footprint
Table 40. Cardiopulmonary Assist System(ECMO) New Market Entrants and Barriers to Market Entry
Table 41. Cardiopulmonary Assist System(ECMO) Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Cardiopulmonary Assist System(ECMO) Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Cardiopulmonary Assist System(ECMO) Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Cardiopulmonary Assist System(ECMO) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Cardiopulmonary Assist System(ECMO) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Cardiopulmonary Assist System(ECMO) Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Cardiopulmonary Assist System(ECMO) Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Cardiopulmonary Assist System(ECMO) Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Cardiopulmonary Assist System(ECMO) Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Cardiopulmonary Assist System(ECMO) Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Cardiopulmonary Assist System(ECMO) Raw Material
Table 101. Key Manufacturers of Cardiopulmonary Assist System(ECMO) Raw Materials
Table 102. Cardiopulmonary Assist System(ECMO) Typical Distributors
Table 103. Cardiopulmonary Assist System(ECMO) Typical Customers
List of Figures
Figure 1. Cardiopulmonary Assist System(ECMO) Picture
Figure 2. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Type in 2022
Figure 4. V-V-ECMO Examples
Figure 5. V-A-ECM Examples
Figure 6. Global Cardiopulmonary Assist System(ECMO) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Application in 2022
Figure 8. Aldult Examples
Figure 9. Newborn Examples
Figure 10. Child Examples
Figure 11. Global Cardiopulmonary Assist System(ECMO) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Cardiopulmonary Assist System(ECMO) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Cardiopulmonary Assist System(ECMO) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Cardiopulmonary Assist System(ECMO) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Cardiopulmonary Assist System(ECMO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Cardiopulmonary Assist System(ECMO) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Cardiopulmonary Assist System(ECMO) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Cardiopulmonary Assist System(ECMO) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Cardiopulmonary Assist System(ECMO) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Cardiopulmonary Assist System(ECMO) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Cardiopulmonary Assist System(ECMO) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Cardiopulmonary Assist System(ECMO) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Cardiopulmonary Assist System(ECMO) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Cardiopulmonary Assist System(ECMO) Market Drivers
Figure 74. Cardiopulmonary Assist System(ECMO) Market Restraints
Figure 75. Cardiopulmonary Assist System(ECMO) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cardiopulmonary Assist System(ECMO) in 2022
Figure 78. Manufacturing Process Analysis of Cardiopulmonary Assist System(ECMO)
Figure 79. Cardiopulmonary Assist System(ECMO) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
